Hdlife Pharma And Labs Private Limited
Founded in 2018 and headquartered in Assam, India.
2018 | Kamrup, Assam (India) | Active
Hdlife Pharma And Labs Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.70 M
- Revenue Growth 11.80%
- Profit Growth -138.98%
- Ebitda -84.51%
- Net Worth -18.38%
- Total Assets -60.80%
About Hdlife Pharma And Labs
Hdlife Pharma And Labs Private Limited (HPALPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 30 May 2018 (Six years and eight months 29 days old ). Its registered office is in Kamrup, Assam, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.70 M.
Anisur Rohman and Shahera Banu serve as directors at the Company.
Company Details
- Location
Kamrup, Assam, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51909AS2018PTC018540
- Company No.
018540
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 May 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Shillong
Industry
Trading
Other Industry
Who are the key members and board of directors at Hdlife Pharma And Labs?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anisur Rohman  | Director | 30-May-2018 | Current |
| Shahera Banu | Director | 02-Dec-2019 | Current |
Financial Performance of Hdlife Pharma And Labs.
Hdlife Pharma And Labs Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 11.8% increase. The company also saw a substantial fall in profitability, with a 138.98% decrease in profit. The company's net worth observed a substantial decline by a decrease of 18.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hdlife Pharma And Labs?
Unlock access to Hdlife Pharma And Labs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
Open Charges
₹0.70 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Others : 0.07 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Feb 2022 | Others | ₹0.70 M | Open |
How Many Employees Work at Hdlife Pharma And Labs?
Unlock and access historical data on people associated with Hdlife Pharma And Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hdlife Pharma And Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hdlife Pharma And Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
